קסנזין 25 מ"ג

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

TETRABENAZINE 25 MG

Disponible desde:

MEGAPHARM LTD

Código ATC:

N07XX06

formulario farmacéutico:

TABLETS

Vía de administración:

PER OS

Fabricado por:

LIFEHEALTH LIMITED, UK

Grupo terapéutico:

TETRABENAZINE

indicaciones terapéuticas:

Movement disorders, associated with organic central nervous system conditions, e.g. Huntington's chorea, hemiballismus and senile chorea.Moderate to severe tardive dyskinesia, which is disabling and/or socially embanassing. The condition should be persistent despite a switch to atypical antipsychotic medication and/or reduction in dosage of antipsychotic medication, when withdrawal of antipsychotic medication is not a realistic option.

Fecha de autorización:

2009-11-01